Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.19.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 52,094 $ 74,867
Short term investments 58,685 53,240
Accounts receivable 7,128 2,701
Prepaid expenses and other current assets 6,379 4,574
Total current assets 124,286 135,382
Property and equipment, net 4,893 5,049
Other non-current assets 1,869 910
Total assets 131,048 141,341
Current liabilities:    
Accounts payable 3,728 3,350
Accrued expenses and other current liabilities 9,216 9,114
Deferred revenues, current portion 28,181 35,612
Total current liabilities 41,125 48,076
Deferred revenue, net of current portion 59,734 53,303
Other long-term liabilities 27 27
Total liabilities 100,886 101,406
Stockholders’ equity:    
Common stock, $0.001 par value per share, 300,000,000 shares authorized and 49,151,219 and 54,151,219 issued and outstanding at March 31, 2019 and December 31, 2018, respectively 49 54
Additional paid-in capital 191,224 189,929
Accumulated other comprehensive loss (2,056) (2,982)
Accumulated deficit (159,055) (147,066)
Total stockholders’ equity 30,162 39,935
Total liabilities and stockholders’ equity 131,048 141,341
Series A Convertible, 2,907 issued and outstanding at March 31, 2019 and December 31, 2018, respectively    
Stockholders’ equity:    
Preferred stock 0 0
Series B Convertible, 5,000 shares issued and outstanding at March 31, 2019. No shares issued and outstanding at December 31, 2018.    
Stockholders’ equity:    
Preferred stock $ 0 $ 0